Company intelligence / Profile preview

IOZK

Cologne, North Rhine-Westphalia, Germanyiozk.de ↗
Ownership
Private
Development stage
Commercial
01

Overview

IOZK offers individualized immunotherapies for cancer patients, primarily combining autologous dendritic cell vaccines with Newcastle Disease Virus vaccine. They have also begun incorporating immune checkpoint inhibitors into their regimens. Their approach is designed to activate the patient’s own immune system against tumor cells, aiming to improve quality of life and potentially influence disease course positively. Complete cures are rare for advanced tumors, but the therapies may provide benefit in disease control and symptom management[1][2].

Therapeutic areas
Oncology
Modalities
Dendritic cell therapyOncolytic virus therapy (Newcastle Disease Virus vaccine)Immune checkpoint inhibitor therapy (incorporated into protocols)
Industry
Biotech
02

Drug pipeline

3 assets

rNDV-18HL

Preclinical

2 more assets in the full pipeline.

Request access →

Beyond the preview

Go deeper on IOZK.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on IOZK.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call